Retinal Endovascular Surgery with Tissue Plasminogen Activator Injection for Central Retinal Artery Occlusion
نویسندگان
چکیده
منابع مشابه
tissue plasminogen activator versus aspirin in central retinal vein occlusion
purpose: to compare the effect of tissue plasminogen activator (tpa) and aspirin in patients with central retinal vein occlusion. methods: a prospective interventional study was conducted on patients with central retinal vein occlusion of less than 28 days' duration. patients in the tpa group received 100 μg intravitreal tissue plasminogen activator and the patients who declined intravitre...
متن کاملIntravitreal injection of tissue plasminogen activator for central retinal vein occlusion.
PURPOSE This pilot study evaluated the feasibility of intravitreal injections of tissue plasminogen activator (tPA) in eyes with central retinal vein occlusion (CRVO). METHODS Between August 1997 and October 2000, 9 eyes with CRVO were treated with intravitreal injection of tPA, 100 micrograms (50 micrograms/0.1 mL), and paracentesis. After the injection, each patient was placed at strict bed...
متن کاملEfficacy of Intravenous Tissue-Type Plasminogen Activator in Central Retinal Artery Occlusion
Background and Purpose—Central retinal artery occlusion is caused by a platelet-fibrin thrombus or embolic occlusion and is a stroke of the eye. Observational studies suggest that thrombolytics may restore ocular perfusion and visual function. We hypothesized that intravenous tissue-type plasminogen activator (tPA) administered within 24 hours of symptom onset might restore ocular perfusion and...
متن کاملCentral Retinal Artery Occlusion Masquerading as Branch Retinal Artery Occlusion
Dear Editor, Retinal artery occlusion (RAO) is characterized by attenuated arterioles and ischemic retinal opacity, which suggest retinal infarction. Branch RAO (BRAO) has a more favorable prognosis than central RAO (CRAO). CRAO and BRAO can be differentiated based on the isch-emic retinal opacity area, location of the attenuated vessels , and a cherry-red spot [1]. However, we encountered a ca...
متن کاملTreatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study.
AIMS To study the effects of intravitreal tissue plasminogen activator (tPA) in recent onset central retinal vein occlusion (CRVO). METHODS 15 patients with recent onset CRVO (from 1-21 days' duration, mean 8 days) were given 75-100 microg of tPA intravitreally associate with low dose low molecular weight heparin. CRVO was perfused in nine patients and with mild ischaemia not exceeding 100 di...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Ophthalmology
سال: 2018
ISSN: 1663-2699
DOI: 10.1159/000489696